Komodo Health is a healthcare technology company creating the new standard for real-world data and analytics through its platform, which enables real-time, accurate, and actionable insight into the treatment, diagnosis, costs, and outcomes journeys of millions of patients across the US.
PicnicHealth provides researchers with the most complete patient-level real-world data (RWD). In the U.S., an individual's medical records are fragmented across numerous sources and formats. PicnicHealth’s unique methodology of collecting records on behalf of consenting patients allows researchers to get the full picture of patients’ experiences across all sites of care. Consenting patients’ data is de-identified, aggregated, and abstracted in a customized manner to answer your priority research questions. PicnicHealth works with researchers across the life sciences, including top biopharma, to advance the development of treatments for better patient outcomes.
Adelphi Real World: Experts in generating real-world data and shaping real-world evidence
Conducting multi-country real-world observational studies for over 25 years, grounded in extensive heritage of Adelphi’s Disease Specific Programmes™, supported by the expansion of our real-world evidence services to meet pharmaceutical client needs.
We provide a unique range of real-world data involving physicians, patients, and caregivers; achieved through our market-leading Disease Specific Programmes™, tailored non-interventional studies, international secondary database analyses and evidence landscaping.
Premier Inc. (NASDAQ: PINC) is a technology-driven healthcare improvement company uniting an alliance of approximately 4,350 U.S. hospitals and health systems and more than 300,000 other providers and organizations to transform healthcare. As an industry leader, Premier has one of the most comprehensive databases of actionable, de-identified real-world data from more than 1,300 sites – integrating clinical, quality and purchasing datasets for deeper insights.
RTI Health Solutions is a collaborative team of experts that have been collecting and analyzing prospective and retrospective real-world data for decades. We stay abreast of evolving methods and guidelines to provide you with knowledgeable support and advice throughout your product development lifecycle. Our team is here to support you with every aspect of a successful evidence-generation program, including clinical, market access, outcomes research, patient preference, economic evaluation, reimbursement, and safety activities.
Aetion delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions—what works best, for whom, and when—to guide product development, commercialization, and payment innovation.
LynxCare mines structured and unstructured hospital data to improve patient outcomes and make highly granular and qualitative Real-World Data accessible for life sciences research. From the pre-clinical development phase and the optimization of clinical trial designs, to measuring the value and safety of a drug, negotiations with payers/HTA bodies and post-marketing studies, LynxCare can assist life sciences to answer research questions throughout the entire drug development life cycle.
